Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
8.63
+0.53 (6.54%)
At close: Aug 1, 2025, 4:00 PM
8.50
-0.13 (-1.51%)
After-hours: Aug 1, 2025, 6:40 PM EDT

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
--97.01-57.51-161.82-122.25-149.91
Upgrade
Depreciation & Amortization
-8.669.2110.119.849.98
Upgrade
Loss (Gain) From Sale of Assets
---0.01--
Upgrade
Stock-Based Compensation
-13.149.817.1916.4114.3
Upgrade
Change in Accounts Receivable
-19.66-21.09-3020
Upgrade
Change in Accounts Payable
-3.42-3.769.35-6.575.12
Upgrade
Change in Unearned Revenue
--93.5954.33-3.25-18.46-20.08
Upgrade
Change in Other Net Operating Assets
--5.32-10.40.622.044.61
Upgrade
Operating Cash Flow
--151.03-19.43-127.78-88.99-115.98
Upgrade
Capital Expenditures
--0.94-1.12-1.36-0.56-1.34
Upgrade
Sale of Property, Plant & Equipment
---0.11--
Upgrade
Investing Cash Flow
--0.94-1.12-1.26-0.56-1.34
Upgrade
Issuance of Common Stock
-239.81132.5352.9255.83154.54
Upgrade
Other Financing Activities
-14.08-14.27--
Upgrade
Financing Cash Flow
-253.89132.5367.1955.83154.54
Upgrade
Foreign Exchange Rate Adjustments
--0.14-0.1-0.21-0.210.12
Upgrade
Net Cash Flow
-101.79111.89-62.06-33.9337.34
Upgrade
Free Cash Flow
--151.96-20.55-129.14-89.55-117.32
Upgrade
Free Cash Flow Margin
--140.31%-18.13%-3539.11%-218.61%-584.35%
Upgrade
Free Cash Flow Per Share
--1.10-0.19-1.64-1.73-2.99
Upgrade
Levered Free Cash Flow
--107.8464.11-67.01-78.24-77.73
Upgrade
Unlevered Free Cash Flow
--107.8464.11-67.01-78.24-77.73
Upgrade
Change in Net Working Capital
83.6559.71-88.72-8.7524.544.81
Upgrade
Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q